Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment

References

• Alejandro F, Bruice J. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 2012;13:750–751.
   PubMed Web of Science ®Google Scholar
• Sufen S, Amelie P, Shaokui G, et al. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology (Baltimore, MD). 2012;55:483–490.
   PubMed Web of Science ®Google Scholar
• Yi-Te L, Chuck CKC. Identification of the beta-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells. Oncotarget. 2015;6:38999–39017.
   PubMedGoogle Scholar
• Roviello G, Petrioli R, Marano L, et al. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. Gastric Cancer. 2016;19:31–41.
   PubMed Web of Science ®Google Scholar
• Yong C, Jalila A, Pamela T, et al. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Cancer Chemoth Pharm. 2007;59:561–574.
   PubMed Web of Science ®Google Scholar
• Tao L, Xiufen C, Yajun L, et al. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer. Eur J Pharm Sci. 2017;1:456–463.
   Google Scholar
• Van Malenstein H, Dekervel J, Verslype C, et al. Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth. Cancer Lett. 2013;329:74–83.
   PubMed Web of Science ®Google Scholar
• Joseph L, Andrew K, William A, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009;27:659–666.
   PubMed Web of Science ®Google Scholar
• Wang T, Wang D, Yu H, et al. Intracellularly acid-switchable multifunctional micelles for combinational photo/chemotherapy of the drug-resistant tumor. ACS Nano. 2016;10:3496–3508.
   PubMed Web of Science ®Google Scholar
• Vikash C, Rakesh J. Strategies for advancing cancer nanomedicine. Nat Mater. 2013;12:958–962.
   PubMed Web of Science ®Google Scholar
• Zhao R, Li T, Zheng G, et al. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitivechitosan-conjugated mesoporous silica nanocomplex. Biomaterials. 2017;22:1–16.
   Google Scholar
• Powell CJ, Werner WS, Shard AG, et al. Evaluation of two methods for determining shell thicknesses of core-shell nanoparticles by X-ray photoelectron spectroscopy. J Phys Chem C Nanomater Interfaces. 2016;120:22730–22738.
   PubMed Web of Science ®Google Scholar
• Slowing II, Trewyn BG, Giri S, et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater. 2007;17:1225–1236.
   Web of Science ®Google Scholar
• Zheng G, Zhao R, Xu A, et al. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy. Eur J Pharm Sci. 2018;1:492–502.
   Google Scholar
• Mert E, Simone H, Christoph WS, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9:454–467.
   PubMed Web of Science ®Google Scholar
• Buckminster F, Danel A. The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res. 2008;149:319–328.
   PubMed Web of Science ®Google Scholar
• Zhao R, Han X, Li Y, et al. Photothermal effect enhanced cascade-targeting strategy for improved pancreatic cancer therapy by gold nanoshell@mesoporous silica nanorod. ACS Nano. 2017;11:8103–8113.
   PubMed Web of Science ®Google Scholar
• Kanamori S, Nishimura Y, Okuno Y, et al. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor. Int J Hyperthermia. 1999;15:267–278.
   PubMed Web of Science ®Google Scholar
• Karino T, Koga S, Maeta M. Experimental studies of the effects of local hyperthermia on blood-flow, oxygen-pressure and pH in Tumors. Jpn J Surg. 1988;18:276–283.
   PubMedGoogle Scholar
• Wen L, Chen L, Zheng S, et al. Ultrasmall biocompatible WO3-xnanodots for multi-modality imaging and combined therapy of cancers. Adv Mater. 2016;28:5072–5079.
   PubMed Web of Science ®Google Scholar
• Meng Y, Fang G, Jinping W, et al. A pH-driven and photoresponsive nanocarrier: remotely-controlled by near-infrared light for stepwise antitumor treatment. Biomaterials. 2016;2:25–35.
   Google Scholar
• Yuchu H, Mengxue Y, Shuxian Z, et al. Regulatory mechanism of localized surface plasmon resonance based on gold nanoparticles coated paclitaxel nanoliposomes and their antitumor efficacy. ACS Sustainable Chem Eng. 2018;6:13543–13550.
   Web of Science ®Google Scholar
• Paciotti GF, Kingston DGI, Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev Res. 2006;67:47–54.
   Web of Science ®Google Scholar
• Guo Y, Zhang ZL, Kim DH, et al. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int J Nanomed. 2013;8:3437–3446.
   PubMed Web of Science ®Google Scholar
• Patino T, Mahajan U, Palankar R, et al. Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using ultra-short pulse near-infrared laser irradiation. Nanoscale. 2015;7:5328–5337.
   PubMed Web of Science ®Google Scholar
• Liang Z, Danli S, Dong W, et al. Bioinspired multifunctional melanin-based nanoliposome for photoacoustic/magnetic resonance imaging-guided efficient photothermal ablation of cancer. Theranostics. 2018;8:1591–1606.
   PubMed Web of Science ®Google Scholar
• Jian Y, Rui Z, Guodong Z, et al. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Controlled Release. 2012;158:319–328.
   PubMed Web of Science ®Google Scholar
• Jiang K, Chi T, Li T, et al. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. Nanoscale. 2018;13:9428–9439.
   Google Scholar
• Hai W, Ruifang Z, Yiye L, et al. Aspect ratios of gold nanoshell capsules mediated melanoma ablation by synergistic photothermal therapy and chemotherapy. Nanomed Nanotechnol. 2016;12:439–448.
   PubMed Web of Science ®Google Scholar
• Hakeem A, Zahid F, Duan R, et al. Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release. Nanoscale. 2016;8:5089–5097.
   PubMed Web of Science ®Google Scholar
• Hartmann M. Ordered mesoporous materials for bioadsorption and biocatalysis. Chem Mater. 2005;17:4577–4593.
   Web of Science ®Google Scholar
• Lee H, Fonge H, Hoang B, et al. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm. 2010;7:1195–1208.
   PubMed Web of Science ®Google Scholar